Filing Flows › Neuraxis (NRXS) › Q2 2026
Neuraxis (NRXS) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 11, 2026
Neuraxis (NRXS) reported revenue of $1.9M for the second quarter 2026 (Q2 2026), +116% from a year earlier and +20% from the quarter before. Operating margin was -110.2%, net loss $2.1M (108.1% of revenue).
Neuraxis, Q2 2026: revenue $1.9M (+116% year over year), operating margin -110.2%, net loss $2.1M, operating cash flow −$1.0M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.9M | +20% | +116% |
| Operating profit | −$2.1M | — | — |
| Net earnings | −$2.1M | — | — |
| Operating cash flow | −$1.0M | — | — |
What changed
Revenue was $1.9M in Q2 2026, up 116% year over year and up 20% from the previous quarter.
Gross margin was 85.9%, up 2.3 points from Q2 2025. Operating costs exceeded revenue by $2.1M, an operating margin of -110.2%. Operating expenses grew 53% against revenue growth of 116%. The fastest-growing cost line was Research & development (+138%). The quarter ended with a net loss of $2.1M, wider than the previous quarter's $1.8M loss.
Operating cash flow was −$1.0M. Non-cash charges added back $17K of depreciation and amortization and $640K of share-based compensation. Working capital and other items added $400K. Capital expenditures of $106K exceeded it, leaving free cash flow of −$1.1M.
Questions
What was Neuraxis' revenue in the second quarter 2026?
Neuraxis (NRXS) reported revenue of $1.9M for the second quarter 2026 (Q2 2026), +116% from a year earlier and +20% from the quarter before.
Was Neuraxis profitable in the second quarter 2026?
Operating loss was $2.1M (-110.2% of revenue) and net loss $2.1M.
Source: Neuraxis 10-Q on SEC EDGAR.